Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06928116 · ClinicalTrials.gov registry record · NA

Heat thErapy And mobiLity in COVID-19 Survivors

A NA study of Long COVID, sponsored by University of Nebraska.

Recruiting
Registry status
NA
Development phase
99
Enrollment target
1
Study location

NCT06928116 is a NA study of Long COVID that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 99 participants, below the 2,186-participant average among 50 other Long COVID trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06928116, a NA study of Long COVID, is actively recruiting participants, sponsored by University of Nebraska.

RECRUITING
Registry status
NA
Development phase
99 participants
Enrollment target
1
Study location

Study Summary

Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".

Conditions Studied

Interventions

  • BEHAVIORAL Sham Control
  • BEHAVIORAL Walking
  • BEHAVIORAL Heat therapy

Study Locations (1)

Nebraska

  • University of Nebraska Omaha - Omaha

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2025-09-17
Est. Completion 2029-08
Phase NA

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT06928116

The ClinicalTrials.gov registry entry for NCT06928116 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,186-participant average among 50 other Long COVID trials with a reported enrollment target (95% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 3 interventions - of which Sham Control is the first listed.

NCT06928116 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT06928116 about?

NCT06928116 is a clinical study titled "Heat thErapy And mobiLity in COVID-19 Survivors". Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restor...

What is the current status of trial NCT06928116?

This trial is currently recruiting. It is a NA study. The enrollment target is 99 participants. The study started on 2025-09-17. Estimated completion is 2029-08.

What conditions does trial NCT06928116 study?

This clinical trial studies the following conditions: Long COVID.

What interventions are being tested in trial NCT06928116?

The interventions under investigation include: Sham Control (BEHAVIORAL), Walking (BEHAVIORAL), Heat therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06928116?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06928116 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.